A carregar...
PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
BACKGROUND: Anti-immune programmed death-ligand 1 (PD-L1) pathway is used by the tumor to overcome immune system and serves as immunotherapy target in various malignancies. AIM: To investigate the expression of PD-L1 in vulvar squamous cell carcinoma (vSCC) and to assess it's clinicopathologica...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5685718/ https://ncbi.nlm.nih.gov/pubmed/29163797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20911 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|